Dagmar Riemann

5PUBLICATIONS

9CO-AUTHORS

Predictive and prognostic markersMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Oct 14, 2023

Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy.

Miriam Möller, Wolfgang Schütte, Steffi Turzer

|Sep 20, 2023

Neuronal Stem Cells from Late-Onset Alzheimer Patients Show Altered Regulation of Sirtuin 1 Depending on Apolipoprotein E Indicating Disturbed Stem Cell Plasticity.

Matthias Jung, Juliane-Susanne Jung, Jenny Pfeifer

|Feb 25, 2023

Monitoring Blood Immune Cells in Patients with Advanced Small Cell Lung Cancer Undergoing a Combined Immune Checkpoint Inhibitor/Chemotherapy.

Dagmar Riemann, Steffi Turzer, Georgi Ganchev

|Aug 12, 2022

Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade.

Miriam Möller, Steffi Turzer, Georgi Ganchev

|Sep 25, 2018

Blood immune cell biomarkers in lung cancer.

D Riemann, M Cwikowski, S Turzer

Pageof 1

Frequent Collaborators

3 joint publications

Barbara Seliger

2 joint publications

Miriam Möller

1 joint publications

Andreas Wienke

1 joint publications

Matthias Jung

1 joint publications

Juliane-Susanne Jung

1 joint publications

Carla Hartmann

1 joint publications

Anne Navarrete Santos

1 joint publications

Thomas Hollemann

1 joint publications

Dan Rujescu

Frequent Collaborators

3 joint publications

Barbara Seliger

2 joint publications

Miriam Möller

1 joint publications

Andreas Wienke

1 joint publications

Matthias Jung